215 related articles for article (PubMed ID: 37440097)
1. Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience.
Matsui JK; Allen PK; Perlow HK; Johnson JM; Paulino AC; McAleer MF; Fouladi M; Grosshans DR; Ghia AJ; Li J; Zaky WT; Chintagumpala MM; Palmer JD; McGovern SL
J Neurooncol; 2023 Jul; 163(3):717-726. PubMed ID: 37440097
[TBL] [Abstract][Full Text] [Related]
2. High-grade gliomas in children and adolescents: is there a role for reoperation?
Silva da Costa MD; Camargo NC; Dastoli PA; Nicácio JM; Benevides Silva FA; Sucharski Figueiredo ML; Chen MJ; Cappellano AM; Saba da Silva N; Cavalheiro S
J Neurosurg Pediatr; 2020 Dec; 27(2):160-169. PubMed ID: 33307529
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of multidisciplinary management in pediatric low-grade gliomas.
Oh KS; Hung J; Robertson PL; Garton HJ; Muraszko KM; Sandler HM; Hamstra DA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e481-8. PubMed ID: 21470783
[TBL] [Abstract][Full Text] [Related]
4. Low-grade gliomas in children: single institutional experience in 198 cases.
Garzón M; García-Fructuoso G; Suñol M; Mora J; Cruz O
Childs Nerv Syst; 2015 Sep; 31(9):1447-59. PubMed ID: 26156776
[TBL] [Abstract][Full Text] [Related]
5. Adult diffuse midline gliomas: Clinical, radiological, and genetic characteristics.
Dono A; Takayasu T; Ballester LY; Esquenazi Y
J Clin Neurosci; 2020 Dec; 82(Pt A):1-8. PubMed ID: 33317715
[TBL] [Abstract][Full Text] [Related]
6. Sex, Age, Anatomic Location, and Extent of Resection Influence Outcomes in Children With High-grade Glioma.
McCrea HJ; Bander ED; Venn RA; Reiner AS; Iorgulescu JB; Puchi LA; Schaefer PM; Cederquist G; Greenfield JP
Neurosurgery; 2015 Sep; 77(3):443-52; discussion 452-3. PubMed ID: 26083157
[TBL] [Abstract][Full Text] [Related]
7. Pediatric supratentorial high-grade glioma: multicenter retrospective observational study of the Korean Society for Pediatric Neuro-Oncology.
Jung TY; Lee JY; Kim DS; Park HJ; Kim CY; Ra YS; Lee MJ; Kim SH; Baek HJ; Kim IH; Park KD; Kim SK
J Neurooncol; 2015 Jan; 121(2):413-9. PubMed ID: 25366367
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics and Prognostic Analysis of Glioma in Human Immunodeficiency Virus-Infected Patients.
Wang T; Gao T; Niu X; Xing X; Yang Y; Liu Y; Mao Q
World Neurosurg; 2018 Jun; 114():e218-e223. PubMed ID: 29524717
[TBL] [Abstract][Full Text] [Related]
9. A multicenter analysis of the prognostic value of histone H3 K27M mutation in adult high-grade spinal glioma.
Akinduro OO; Garcia DP; Higgins DMO; Vivas-Buitrago T; Jentoft M; Solomon DA; Daniels DJ; Pennington Z; Sherman WJ; Delgardo M; Bydon M; Kalani MA; Zanazzi G; Tsankova N; Bendok BR; McCormick PC; Sciubba DM; Lo SL; Clarke JL; Abode-Iyamah K; Quiñones-Hinojosa A
J Neurosurg Spine; 2021 Aug; 35(6):834-843. PubMed ID: 34416733
[TBL] [Abstract][Full Text] [Related]
10. Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.
Chi AS; Tarapore RS; Hall MD; Shonka N; Gardner S; Umemura Y; Sumrall A; Khatib Z; Mueller S; Kline C; Zaky W; Khatua S; Weathers SP; Odia Y; Niazi TN; Daghistani D; Cherrick I; Korones D; Karajannis MA; Kong XT; Minturn J; Waanders A; Arillaga-Romany I; Batchelor T; Wen PY; Merdinger K; Schalop L; Stogniew M; Allen JE; Oster W; Mehta MP
J Neurooncol; 2019 Oct; 145(1):97-105. PubMed ID: 31456142
[TBL] [Abstract][Full Text] [Related]
11. Impact of Intraoperative Magnetic Resonance Imaging and Other Factors on Surgical Outcomes for Newly Diagnosed Grade II Astrocytomas and Oligodendrogliomas: A Multicenter Study.
Yahanda AT; Patel B; Shah AS; Cahill DP; Sutherland G; Honeycutt J; Jensen RL; Rich KM; Dowling JL; Limbrick DD; Dacey RG; Kim AH; Leuthardt EC; Dunn GP; Zipfel GJ; Leonard JR; Smyth MD; Shah MV; Abram SR; Evans J; Chicoine MR
Neurosurgery; 2020 Dec; 88(1):63-73. PubMed ID: 32717067
[TBL] [Abstract][Full Text] [Related]
12. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma.
Pachocki CJ; Hol EM
J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059
[TBL] [Abstract][Full Text] [Related]
13. Dose-intensified chemoradiation is associated with altered patterns of failure and favorable survival in patients with newly diagnosed glioblastoma.
Kim MM; Speers C; Li P; Schipper M; Junck L; Leung D; Orringer D; Heth J; Umemura Y; Spratt DE; Wahl DR; Cao Y; Lawrence TS; Tsien CI
J Neurooncol; 2019 Jun; 143(2):313-319. PubMed ID: 30977058
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors effective on survival of patients with glioblastoma: Anadolu Medical Center experience.
Guden M; Ayata HB; Ceylan C; Kilic A; Engin K
Indian J Cancer; 2016; 53(3):382-386. PubMed ID: 28244465
[TBL] [Abstract][Full Text] [Related]
15. Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.
Palmer JD; Siglin J; Yamoah K; Dan T; Champ CE; Bar-Ad V; Werner-Wasik M; Evans JJ; Kim L; Glass J; Farrell C; Andrews DW; Shi W
J Neurooncol; 2015 Sep; 124(2):215-21. PubMed ID: 26024653
[TBL] [Abstract][Full Text] [Related]
16. Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas.
Wang C; Liu S; Peng L; Zhang K; Li W; Zhang H; Luan Y; Li P; Hu X
BMC Cancer; 2020 Jun; 20(1):591. PubMed ID: 32580723
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
18. Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.
Koo T; Lim DH; Seol HJ; Dho YS; Kim IH; Chang JH; Lee J; Jung TY; Gwak HS; Cho KH; Hong CK; Lee IJ; Kim E; Kim JH; Hong YK; Jang HS; Kim CY; Kim IA; Kim SH; Kim YI; Kim EY; Kim WC; Hong S
J Neurooncol; 2018 Nov; 140(2):445-455. PubMed ID: 30097825
[TBL] [Abstract][Full Text] [Related]
19. Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma.
Chai RC; Yan H; An SY; Pang B; Chen HY; Mu QH; Zhang KN; Zhang YW; Liu YQ; Liu X; Zhao Z; Jiang T; Wang YZ; Jia WQ
Brain Pathol; 2023 Jul; 33(4):e13153. PubMed ID: 36751054
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological characteristics and prognosis of diffuse midline gliomas with histone H3K27M mutation: an analysis of 30 cases].
Li HN; Shan CG; Fan CZ; Cheng LN; Wu SG; Liu MT; Jiang GY; Li Z
Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):192-198. PubMed ID: 30831644
[No Abstract] [Full Text] [Related]
[Next] [New Search]
